Search research articles
Contact Us
Filters
Showing results (71-80 of 102) with videos related to
Page
of 11
Sort By:
The Journal of Biological Chemistry
|
July 17, 2016
Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone
Sambad Sharma, Fei Xing, Yin Liu, et al.
The Journal of Urology
|
November 21, 2002
Role of advanced 2 and 3-dimensional ultrasound for detecting prostate cancer
K C Balaji, William R Fair, Ernst J Feleppa, et al.
Cancer Gene Therapy
|
April 20, 2022
3JC48-3 (methyl 4'-methyl-5-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)-[1,1'-biphenyl]-3-carboxylate): a novel MYC/MAX dimerization inhibitor reduces prostate cancer growth
Sanjeev Shukla, Steven Fletcher, Jay Chauhan, et al.
Cureus
|
September 2, 2025
Role of Lymph Node Dissection in Commonly Diagnosed Solid Organ Malignancies With High Mortality Rates: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Soroush Bazargani, Srivani Sanikommu, Seyed Behzad Jazayeri, et al.
Urologic Oncology
|
November 23, 2005
Tissue transglutaminase interacts with protein kinase A anchor protein 13 in prostate cancer
Tamra E Lewis, Terry D Milam, Douglas W Klingler, et al.
Investigational New Drugs
|
February 20, 2026
A novel aurora kinase molecular glue-based degrader sp-2-067 inhibits prostate cancer cell growth and alters immune profile
Sanjeev Shukla, Sarah Pogash, Arjun Venkatesh, et al.
Current Urology
|
November 23, 2023
Can magnetic resonance imaging differentiate muscle invasion (T2) and lamina propria invasion (T1) urothelial carcinoma of the bladder? A systematic review and meta-analysis of Vesical Imaging-Reporting and Data System accuracy
Seyed Behzad Jazayeri, Hojat Dehghanbanadaki, Mahdie Hosseini, et al.
The Prostate
|
October 21, 2024
Protein kinase D1 mitigation against etoposide induced DNA damage in prostate cancer is associated with increased α-Catenin
Sanjeev Shukla, Teruko Osumi, Mohammed Al-Toubat, et al.
The Prostate
|
April 17, 2026
Protein Kinase D1 Translocates PARP1 to the Membrane and Is Associated With Increased Sensitivity to Cell Viability Inhibition by PARP1 Inhibitor Olaparib
Sanjeev Shukla, Joseph McGrath, Robert Willis, et al.
Urologic Oncology
|
June 7, 2025
Sex-based differences in genetic alterations and immune checkpoint inhibitor response in urothelial bladder cancer
Jean-Pierre Trey Kanumuambidi, Reynier Rodriguez Rosales, Arjun Venkatesh, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 102) with videos related to
Sort By:
Page
of 11
The Journal of Biological Chemistry
|
July 17, 2016
Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone
Sambad Sharma, Fei Xing, Yin Liu, et al.
The Journal of Urology
|
November 21, 2002
Role of advanced 2 and 3-dimensional ultrasound for detecting prostate cancer
K C Balaji, William R Fair, Ernst J Feleppa, et al.
Cancer Gene Therapy
|
April 20, 2022
3JC48-3 (methyl 4'-methyl-5-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)-[1,1'-biphenyl]-3-carboxylate): a novel MYC/MAX dimerization inhibitor reduces prostate cancer growth
Sanjeev Shukla, Steven Fletcher, Jay Chauhan, et al.
Cureus
|
September 2, 2025
Role of Lymph Node Dissection in Commonly Diagnosed Solid Organ Malignancies With High Mortality Rates: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Soroush Bazargani, Srivani Sanikommu, Seyed Behzad Jazayeri, et al.
Urologic Oncology
|
November 23, 2005
Tissue transglutaminase interacts with protein kinase A anchor protein 13 in prostate cancer
Tamra E Lewis, Terry D Milam, Douglas W Klingler, et al.
Investigational New Drugs
|
February 20, 2026
A novel aurora kinase molecular glue-based degrader sp-2-067 inhibits prostate cancer cell growth and alters immune profile
Sanjeev Shukla, Sarah Pogash, Arjun Venkatesh, et al.
Current Urology
|
November 23, 2023
Can magnetic resonance imaging differentiate muscle invasion (T2) and lamina propria invasion (T1) urothelial carcinoma of the bladder? A systematic review and meta-analysis of Vesical Imaging-Reporting and Data System accuracy
Seyed Behzad Jazayeri, Hojat Dehghanbanadaki, Mahdie Hosseini, et al.
The Prostate
|
October 21, 2024
Protein kinase D1 mitigation against etoposide induced DNA damage in prostate cancer is associated with increased α-Catenin
Sanjeev Shukla, Teruko Osumi, Mohammed Al-Toubat, et al.
The Prostate
|
April 17, 2026
Protein Kinase D1 Translocates PARP1 to the Membrane and Is Associated With Increased Sensitivity to Cell Viability Inhibition by PARP1 Inhibitor Olaparib
Sanjeev Shukla, Joseph McGrath, Robert Willis, et al.
Urologic Oncology
|
June 7, 2025
Sex-based differences in genetic alterations and immune checkpoint inhibitor response in urothelial bladder cancer
Jean-Pierre Trey Kanumuambidi, Reynier Rodriguez Rosales, Arjun Venkatesh, et al.
Page
of 11